These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 25282685

  • 1. Serum concentrations of galectin-3 in patients with cardiac syndrome X.
    Bozcali E, Polat V, Aciksari G, Opan S, Bayrak IH, Paker N, Karakaya O.
    Atherosclerosis; 2014 Nov; 237(1):259-63. PubMed ID: 25282685
    [Abstract] [Full Text] [Related]

  • 2. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E, Karakaş MF, Kurt M, Motor S, Akçay AB, Büyükkaya S, Karakaş E, Sen N.
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X.
    Eroglu S, Elif Sade L, Yildirir A, Demir O, Bozbas H, Muderrisoglu H.
    Acta Cardiol; 2009 Apr; 64(2):207-11. PubMed ID: 19476113
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X.
    Dollard J, Kearney P, Clarke G, Moloney G, Cryan JF, Dinan TG.
    Brain Behav Immun; 2015 Jan; 43():27-32. PubMed ID: 25064176
    [Abstract] [Full Text] [Related]

  • 5. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
    Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC.
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X).
    Ong P, Sivanathan R, Borgulya G, Bizrah M, Iqbal Y, Andoh J, Gaze D, Kaski JC.
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):239-44. PubMed ID: 22392186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X.
    Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Gomez MA, Kaski JC.
    Atherosclerosis; 2010 Dec; 213(2):637-41. PubMed ID: 20980002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X.
    Altiparmak IH, Erkus ME, Sezen H, Demirbag R, Kaya Z, Sezen Y, Gunebakmaz O, Asoglu R, Besli F, Neselioglu S, Erel O.
    Coron Artery Dis; 2016 Jun; 27(4):295-301. PubMed ID: 26928883
    [Abstract] [Full Text] [Related]

  • 12. Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X.
    Sestito A, Lanza GA, Di Monaco A, Lamendola P, Careri G, Tarzia P, Pinnacchio G, Battipaglia I, Crea F.
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):322-7. PubMed ID: 21135582
    [Abstract] [Full Text] [Related]

  • 13. Elevated serum gamma-glutamyl transferase activity in patients with cardiac syndrome X and its relationship with carotid intima media thickness.
    Yagmur J, Ermis N, Acikgoz N, Cansel M, Atas H, Karakus Y, Pekdemir H, Ozdemir R.
    Acta Cardiol; 2010 Oct; 65(5):515-9. PubMed ID: 21125972
    [Abstract] [Full Text] [Related]

  • 14. Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X.
    Gur M, Yildiz A, Demirbag R, Yilmaz R, Koçyigit A, Celik H, Aksoy N.
    Mutat Res; 2007 Apr 01; 617(1-2):8-15. PubMed ID: 17261316
    [Abstract] [Full Text] [Related]

  • 15. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X.
    Arroyo-Espliguero R, Mollichelli N, Avanzas P, Zouridakis E, Newey VR, Nassiri DK, Kaski JC.
    Eur Heart J; 2003 Nov 01; 24(22):2006-11. PubMed ID: 14613736
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The fibrosis marker galectin-3 and outcome in the general population.
    de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P.
    J Intern Med; 2012 Jul 01; 272(1):55-64. PubMed ID: 22026577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.